Rare diseases
Investigational molecules
Locations
Albert-Einstein-Allee 23, Eselsberg, 89081 Ulm, Germany
Institut fuer Klinische Transfusionsmedizin und Immungenetik Ulm gGmbH in Ulm, Germany specialises in clinical trials of conditions such as Colitis ulcerative, Crohn's disease, Breast cancer, Chronic lymphocytic leukaemia, and other specialisations. This site conducts important research.
At Institut fuer Klinische Transfusionsmedizin und Immungenetik Ulm gGmbH, clinical research is centered on immune system diseases, with a strong focus on Paroxysmal Nocturnal Hemoglobinuria. The studies are designed to better understand this rare condition and to assess new treatment options that may improve long-term disease control and patient well-being.
With 8 trials and 96 investigators involved, the site in Ulm contributes to advancing care for rare hematologic and immunologic diseases through focused clinical evaluation.
Clinical trials currently enrolling participants at this site.
GermanyRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
GermanyGermanyLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
GermanyOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
GermanyA study to evaluate the effectiveness and safety of pridopidine hydrochloride in patients with amyotrophic lateral sclerosis
GermanyA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
GermanyA study to evaluate the effectiveness and safety of usnoflast in adults with Amyotrophic Lateral Sclerosis (ALS)
GermanyStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
GermanyA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
GermanyA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
GermanyA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
GermanyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
